Journal Mobile Options
Table of Contents
Vol. 3, No. 5, 1996
Issue release date: 1996
Forsch Komplemetärmed 1996;3:230–234

A Meta-Analysis of the Homeopathic Treatment of Pollinosis with Galphimia glauca

Wiesenauer M. · Lüdtke R.
aMedizinische Fakultät, Universität Göttingen bInstitut für Medizinische Informationsverarbeitung, Universität Tübingen

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: 1) To assess the efficacy of homeopathically prepared Galphimia glauca compared with placebo in the treatment of pollinosis; 2) to estimate the corresponding overall success rate of Galphimia glauca. Design: Meta-analysis of clinical trials. Study Selection: Seven randomized double-blind placebo-controlled trials and 4 non-placebo-controlled trials (1 randomized and controlled, 1 prospective and uncontrolled) performed by our study group between 1980 and 1989. An additonal MEDLINE search revealed no further trials on this topic. Exclusion and inclusion criteria were identical over all trials. In total, 1,038 ambulatory patients who suffered from acute pollinosis (752 in placebo-controlled trials) entered the analysis. Main Outcome Measures: Relative frequency and relative change for showing noticeable and soothing relief in ocular symptoms as assessed by the patient. Results: The overall rate of improved eye symptoms is about 1.25 [confidence interval (CI): 1.09–1.43] times higher in the verum group than in the placebo group. Verum success rate is estimated by 79.3% (CI: 74.1–85.0%). Across the single studies the results were highly comparable except for the study run in 1985. Conclusions: A significant superiority of Galphimia glauca over placebo is demonstrated. Estimates of verum success rates are comparable with those of conventional antihistaminics, but no side effects occurred. The results may be slightly biased since not all of the single studies were analyzed by intention-to-treat analysis.

 goto top of outline Author Contacts

Dr. med. Markus Wiesenauer, Lehrbeauftragter für Allgemeinmedizin der Universität Göttingen, In der Geiss 8, D-71384 Weinstadt (Deutschland)

 goto top of outline Article Information

Number of Print Pages : 5

 goto top of outline Publication Details

Forschende Komplementärmedizin / Research in Complementary Medicine (Research Practice Perspectives - Wissenschaft Praxis Perspektiven)

Vol. 3, No. 5, Year 1996 (Cover Date: 1996)

Journal Editor: Walach H. (Northampton)
ISSN: 1661-4119 (Print), eISSN: 1661-4127 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50